R01 NS076517/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2011	3
2012	13
2013	20
2014	15
2015	12
2016	15
2017	13
2018	10
2019	11
2020	7
2021	10
2022	6
2023	3
2024	1

1

Development of non-sedating antischistosomal benzodiazepines.

Mian MY, Sharmin D, Mondal P, Belayet JB, Hossain MM, McCusker P, Ryan KT, Fedorov AY, Green HA, Ericksen SS, Zamanian M, Tiruveedhula VVNPB, Cook JM, Chan JD. Mian MY, et al. bioRxiv [Preprint]. 2024 Jan 29:2024.01.26.577323. doi: 10.1101/2024.01.26.577323. bioRxiv. 2024. PMID: 38352313 Free PMC article. Preprint.

2

Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation.

Pandey KP, Divović B, Rashid F, Golani LK, Cerne R, Zahn NM, Meyer MJ, Arnold LA, Sharmin D, Mian MY, Smith JL, Ping X, Jin X, Lippa A, Tiruveedhula VVNPB, Cook JM, Savić MM, Witkin JM. Pandey KP, et al. J Pharmacol Exp Ther. 2023 Apr;385(1):50-61. doi: 10.1124/jpet.122.001362. Epub 2023 Feb 6. J Pharmacol Exp Ther. 2023. PMID: 36746611 Free PMC article.

3

High amount of lecithin facilitates oral delivery of a poorly soluble pyrazoloquinolinone ligand formulated in lipid nanoparticles: Physicochemical, structural and pharmacokinetic performances.

Mitrović JR, Divović-Matović B, Knutson DE, Petković M, Djorović D, Randjelović DV, Dobričić VD, Đoković JB, Lunter DJ, Cook JM, Savić MM, Savić SD. Mitrović JR, et al. Int J Pharm. 2023 Feb 25;633:122613. doi: 10.1016/j.ijpharm.2023.122613. Epub 2023 Jan 16. Int J Pharm. 2023. PMID: 36657554 Free PMC article.

4

Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers.

Pareek T, Overton JS, Nguyen LT, Rahman MT, Sharmin D, Cook JM, Platt DM. Pareek T, et al. Drug Alcohol Depend. 2023 Feb 1;243:109735. doi: 10.1016/j.drugalcdep.2022.109735. Epub 2022 Dec 10. Drug Alcohol Depend. 2023. PMID: 36549228 Free PMC article.

5

Effects of α5 GABA_A receptor modulation on social interaction, memory, and neuroinflammation in a mouse model of Alzheimer's disease.

Aranđelović J, Santrač A, Batinić B, Todorović L, Stevanović V, Tiruveedhula VVNPB, Sharmin D, Rashid F, Stanojević B, Cook JM, Savić MM. Aranđelović J, et al. CNS Neurosci Ther. 2022 Nov;28(11):1767-1778. doi: 10.1111/cns.13914. Epub 2022 Jul 13. CNS Neurosci Ther. 2022. PMID: 35822698 Free PMC article.

6

Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress.

Bernardo A, Lee P, Marcotte M, Mian MY, Rezvanian S, Sharmin D, Kovačević A, Savić MM, Cook JM, Sibille E, Prevot TD. Bernardo A, et al. Neuropsychopharmacology. 2022 Aug;47(9):1608-1619. doi: 10.1038/s41386-022-01360-y. Epub 2022 Jun 14. Neuropsychopharmacology. 2022. PMID: 35701547 Free PMC article.

7

Completion of the Total Synthesis of Several Bioactive Sarpagine/Macroline Alkaloids including the Important NF-κB Inhibitor N₄-Methyltalpinine.

Rahman MT, Tiruveedhula VVNPB, Stephen MR, Rallapalli SK, Pandey KP, Cook JM. Rahman MT, et al. Molecules. 2022 Mar 7;27(5):1738. doi: 10.3390/molecules27051738. Molecules. 2022. PMID: 35268836 Free PMC article.

8

Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABA_A receptors.

Souza AJ, Cortez IL, Silva NR, Pedrazzi JFC, Domingos LB, Braga MS, Santos-Silva T, Del-Bel EA, Resstel LBM, Li G, Mian MY, Sharmin D, Guimarães FS, Cook JM, Gomes FV. Souza AJ, et al. Behav Brain Res. 2022 Jun 25;428:113832. doi: 10.1016/j.bbr.2022.113832. Epub 2022 Mar 5. Behav Brain Res. 2022. PMID: 35259414

9

GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABA_A receptors.

Cerne R, Lippa A, Poe MM, Smith JL, Jin X, Ping X, Golani LK, Cook JM, Witkin JM. Cerne R, et al. Pharmacol Ther. 2022 Jun;234:108035. doi: 10.1016/j.pharmthera.2021.108035. Epub 2021 Nov 16. Pharmacol Ther. 2022. PMID: 34793859 Free PMC article. Review.

10

Positive and Negative Selective Allosteric Modulators of α5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's Disease.

Aranđelović J, Santrač A, Batinić B, Todorović L, Ahmed Khan MZ, Rashid F, Poe MM, Obradović A, Cook JM, Savić MM. Aranđelović J, et al. J Alzheimers Dis. 2021;84(3):1291-1302. doi: 10.3233/JAD-215079. J Alzheimers Dis. 2021. PMID: 34657887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

112 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year